NEW YORK, May 20 (GenomeWeb News) - Epoch Biosciences has expanded its licensing agreement with Celera Diagnostics for two of its probe technologies, Epoch said today.
The amended agreement expands Celera's rights to include Epoch's minor groove binder technology, MGB, and its quencher technology, Dark Quencher, into selected infectious disease products.
Epoch first licensed the technology to Celera in January.